Stem cell breakthrough trial aims to halt diabetes attack

NCT ID NCT00690066

Summary

This study tested whether stem cell injections could protect the body's insulin-producing cells in people recently diagnosed with type 1 diabetes. Researchers gave 63 participants either the stem cell treatment or a placebo to see if it could slow or stop the immune system's attack on the pancreas. The goal was to help patients produce more of their own insulin and reduce their need for insulin injections.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • AM Diabetes & Endocrinology Center

    Bartlett, Tennessee, 38133, United States

  • American Health Research, Inc.

    Charlotte, North Carolina, 28207, United States

  • Clinical and Transitional Science Institute

    Milwaukee, Wisconsin, 53226, United States

  • Cumberland Valley Endocrinology

    Carlisle, Pennsylvania, 17015, United States

  • Desert Endocrinology CRC

    Henderson, Nevada, 89052, United States

  • Diabetes Research Institute

    Miami, Florida, 33136, United States

  • Nevada Alliance Against Diabetes

    Las Vegas, Nevada, 89101, United States

  • Optimum Clinical Research, Inc.

    Salt Lake City, Utah, 84102, United States

  • Providence Health Partners - Center for Clinical Research

    Dayton, Ohio, 45439, United States

  • Scripps Whittier Diabetes Institute

    La Jolla, California, 92037, United States

  • Stanford University

    Stanford, California, 94305, United States

  • The Lindner Clinical Trial Center

    Cincinnati, Ohio, 45219, United States

  • The Strelitz Diabetes Center, Eastern VA Medical School

    Norfolk, Virginia, 23510, United States

  • The University of Texas Southwestern Medical Center

    Dallas, Texas, 75390, United States

  • University of Alabama, Division of Endocrinology & Metabolism

    Birmingham, Alabama, 35294, United States

  • University of Florida

    Gainesville, Florida, 32610, United States

  • University of Kentucky

    Lexington, Kentucky, 40502, United States

  • University of Minnesota

    Minneapolis, Minnesota, 55455, United States

  • University of North Carolina Diabetes Care Center

    Chapel Hill, North Carolina, 27599, United States

  • University of Wisconsin Health- West Clinic

    Madison, Wisconsin, 53717, United States

Conditions

Explore the condition pages connected to this study.